Differences in beta-adrenergic receptor sensitivity between women and men with panic disorder

European Neuropsychopharmacology

Volumn 14, Issue 6, 2004, Pages 515-520

  Kim, Youl Ri ^a   Kil Min, Sung ^b   Yu, Bum Hee ^a  

^a Sungkyunkwan University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Beta adrenergic receptor; Chronotropic 25 dose; Gender difference; Isoproterenol; Panic disorder

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR; ISOPRENALINE;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; BODY WEIGHT; CHRONOTROPISM; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PARKINSON DISEASE; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADRENERGIC BETA-AGONISTS; ADULT; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; ISOPROTERENOL; MALE; PANIC DISORDER; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, ADRENERGIC, BETA; SEX CHARACTERISTICS;

EID: 10344239873     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2004.03.004     Document Type: Article

References (42)

1. Abelson J.L., Cameron O.G. Adrenergic dysfunction in anxiety disorders. Cameron O.G. Adrenergic Dysfunction and Psychobiology. 1994;365-401 American Psychiatric Press, Washington, DC
2. Aronson T.A., Carasiti I., McBane D., Whitaker-Azmitiam P. Biological correlates of lactate sensitivity in panic disorder. Biol. Psychiatry. 26:1989;463-477
3. Beck A.T., Ward C.H., Mendelson M., Mock Je., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry. 4:1961;561-571
4. Bremner J.D., Krystal J.H., Southwick S.M., Charney D.S. Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse. 23:1996;39-51
5. Brown S.-L., Charney D.S., Woods S.W., Heninger G.R., Tallman J. Lymphocyte beta-adrenergic receptor binding in panic disorder. Psychopharmacology (Berl.). 94:1998;24-28
6. Cameron O.G., Kuttesch D., McPhee K., Curtis G.C. Menstrual fluctuation in the symptoms of panic anxiety. J. Affect. Disord. 15:1988;169-174
7. Chambless D.L., Mason J. Sex, sex-role stereotyping and agoraphobia. Behav. Res. Ther. 24:1986;231-235
8. Charney D.S., Woods S.W., Krystal J.H., Nagy L.M., Heninger G.R. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients. Acta Psychiatr. Scand. 86:1992;273-282
9. Cleaveland C., Rangno R., Shand D. A standardized isoproterenol sensitivity test. Arch. Intern. Med. 130:1972;47-52
10. Dao T.T., Kailasam M.T., Parmer R.J., Le H.V., Le Verge R., Kennedy B.P., Ziegler G., Insel P.A., Wright F.A., Oconnor D.T. Expression of altered alpha 2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension. J. Hypertens. 16:1998;779-792
11. De Bortoli M.A., Garraza M.H., Aguado L.I. Adrenergic intracerebroventricular stimulation affects progesterone concentration in the ovarian vein of the rat: participation of the superior ovarian nerve. J. Endocrinol. 159:1998;61-68
12. Eaton W.W., Kessler R.C., Wittchen H.U., Magee W.J Panic and panic disorder in the United States. Am. J. Psychiatry. 151:1994;413-420
13. Facchinetti F., Romano G., Fava M., Genazzani A.R. Lactate infusion induces panic attacks in patients with premenstrual syndrome. Psychosom. Med. 54:1992;288-296
14. Fernandez-Ruiz J.J., Bukhari A.R., Martinez-Arrieta R., Tresguerres J.A., Ramos J.A Effects of estrogens and progesterone on the catecholaminergic activity of the adrenal medulla in female rats. Life Sci. 42:1988;1019-1028
15. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders-Clinician Version (SCID-CV). 1997;American Psychiatric Press, Washington, DC
16. Fujita F., Diener E., Sandvik E. Gender differences in negative affect and well-being: the case for emotional intensity. J. Pers. Soc. Psychol. 61:1991;427-434
17. Garvey M.J., Tollefson G.D., Orsulak P.J. Elevations of urinary MHPG in depressed patients with panic attacks. Psychiatry Res. 20:1987;183-187
18. Guy, W., 1976. ECDEU Assessment manual for psychopharmacology. US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration.
19. Hamilton M. The assessment of anxiety states by rating. Br. J. Med. Psychol. 32:1959;50
20. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 23:1960;56
21. Harrison W.M., Sandberg D., Gorman J.M., Fyer M., Nee J., Uy J., Endicott J. Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria. Psychiatry Res. 27:1989;183-192
22. Johnson M. The beta-adrenoceptor. Am. J. Respir. Crit. Care Med. 158(5 Pt. 3):1998;S146-S153
23. Johnson M.R., Lydiard R.B. The neurobiology of anxiety disorders. Psychiatr. Clin. North Am. 18:1995;681-725
24. Joyce P.R., Bushnell J.A., Oakley-Browne M.A., Wells J.E., Hornblow A.R. The epidemiology of panic symptomatology and agoraphobic avoidance. Compr. Psychiatry. 30:1989;303-312
25. Joyce J.N., Lexow N., Kim S.J., Artymyshyn R., Senzon S., Lawrence D., Cassanova M.F., Kleinman J.E., Bird E.D., Winokur A. Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: alterations in limbic regions of schizophrenics. Synapse. 10:1992;228-246
26. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry. 51:1994;8-19
27. Le Melledo J.M., Bradwejn J., Koszycki D., Bichet D. Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide. Arch. Gen. Psychiatry. 52:1995;605-606
28. Le Melledo J.M., Van Driel M., Coupland N.J., Lott P., Jhangri G.S. Response to flumazenil in women with premenstrual dysphoric disorder. Am. J. Psychiatry. 157:2000;821-823
29. Liebowitz M.R., Fyer A.J., Gorman J.M., Dillon D., Appleby I.L., Levy G., Anderson S., Levitt M., Palij M., Davies S.O., Klein D.F. Lactate provocation of panic attacks: I. Clinical and behavioral findings. Arch. Gen. Psychiatry. 41:1984;764-770
30. Maddock R.J., Carter C.S., Magliozzi J.R., Gietzen D.W. Evidence that decreased function of lymphocyte beta-adrenoceptors reflects regulatory and adaptive processes in panic disorder with agoraphobia. Am. J. Psychiatry. 150:1993;1219-1225
31. Mills P.J., Dimsdale J.E., Coy T.V., Ancoli-Israel S., Clausen J.L., Nelesen R.A. Beta 2-adrenergic receptor characteristics in sleep apnea patients. Sleep. 18:1995;39-42
32. Nesse R.M., Cameron O.G., Curtis G.C., McCann D.S., Huber-Smith M.J. Adrenergic function in patients with panic anxiety. Arch. Gen. Psychiatry. 41:1984;771-776
33. Pandey G.N., Janicak P.G., Davis J.M. Decreased beta-adrenergic receptors in the leukocytes of depressed patients. Psychiatry Res. 22:1987;265-273
34. Reiss S., Peterson R.A., Gursky D.M., McNally R.J. Anxiety sensitivity, anxiety frequency, and the prediction of fearfulness. Behav. Res. Ther. 24:1986;1-8
35. Remme W.J. The sympathetic nervous system and ischemic heart disease. Eur. Heart J. 19(Suppl. F):1998;F62-F71
36. Scheibe G., Albus M. Age at onset, precipitating events, sex distribution, and co-occurrence of anxiety disorder. Psychopathology. 25:1992;11-18
37. Spielberger C., Gorsuch R., Lushene R., Vagg P., Facobs G. Manual for the State-Trait Anxiety Inventory, STAI (Form Y). 1983;Consulting Psychologists Press, Palo Alto
38. Stein M.B., Asmundson G.J. Autonomic function in panic disorder: cardiorespiratory and plasma catecholamine responsivity to multiple challenges of the autonomic nervous system. Biol. Psychiatry. 36:1994;548-558
39. Stein M.B., Tancer M.E., Uhde T.W. Heart rate and plasma norepinephrine responsivity to orthostatic challenge in anxiety disorders; comparison of patients with panic disorder and social phobia and normal control subjects. Arch. Gen. Psychiatry. 49:1992;311-317
40. Tan K.S., McFarlane L.C., Coutie W.J., Lipworth B.J. Effects of exogenous female sex-steroid hormones on lymphocyte beta 2-adrenoceptors in normal females. Br. J. Clin. Pharmacol. 41:1996;414-416
41. Wheeldon N.M., Newnham D.M., Coutie W.J., Peters J.A., McDevitt D.G., Lipworth B.J. Influence of sex-steroid hormones on the regulation of lymphocyte beta 2-adrenoceptors during the menstrual cycle. Br. J. Clin. Pharmacol. 37:1994;583-588
42. Woods S.W., Charney D.S., McPherson C.A., Gradman A.H., Heninger G.R. Situational panic attacks: behavioral, physiologic, and biochemical characterization. Arch. Gen. Psychiatry. 44:1987;365-375